|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
|
|---|---|---|---|---|---|
| Assets | |||||
| Cash and cash equivalents | |||||
| Certificates of deposit in other financial institutions | |||||
| Investment securities: | |||||
| Available-for-sale, (amortized cost of $113,976 and $121,879 at September 30, 2026 and December 31, 2025, respectively) | |||||
| Held-to-maturity, at amortized cost | |||||
| Federal Home Loan Bank of Chicago stock (FHLB) | |||||
| Bankers Bank stock | |||||
| Real Estate Owned (REO) | |||||
| Loans receivable, net of allowance for credit losses of $2,962 and $2,682 at September 30, 2026 and December 31, 2025, respectively | |||||
| Premises and equipment, net | |||||
| Accrued interest receivable | |||||
| Bank-owned life insurance (BOLI) | |||||
| Core deposit intangibles | |||||
| Deferred tax assets | |||||
| Other assets | |||||
| Total assets | |||||
| Liabilities and Stockholders' Equity | |||||
| Liabilities: | |||||
| Deposits | |||||
| Advances from borrowers for taxes and insurance | |||||
| Federal funds purchased | |||||
| Accounts payable and accrued expenses | |||||
| Total liabilities | |||||
| Stockholders' Equity: | |||||
| Common stock, $0.01 par value, 9,500,000 shares authorized, 8,096,938 issued and outstanding | |||||
| Unallocated common stock - ESOP | |||||
| Additional paid-in capital | |||||
| Retained earnings | |||||
| Accumulated other comprehensive loss | |||||
| Total stockholders' equity | |||||
| Total liabilities and stockholders' equity |
Loading...